Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Study to Assess if Aspirin 162 mg is Better Than 81 mg for Embryo Transfer Outcomes

NCT06128395 is registered in ClinicalTrials.gov with Clinique Ovo as lead sponsor.

NCT NCT06128395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06128395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Study to Assess if Aspirin 162 mg is Better Than 81 mg for Embryo Transfer Outcomes
Lead sponsor
Clinique Ovo
Phase
Observational
Overall status
Completed
Start date
November 1, 2023
Completion date
September 18, 2024
Enrollment
1,207 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fertility disorders